ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

November 5, 1976

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

NAS Committee Urges Greater Rewards For Interdisciplinary Research.

January 21, 2005

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Conference Bill Includes Funding For DOD For Breast, Prostate, Ovarian Cancer

October 4, 1996

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

July 3, 1998